company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q2,2010-04-04,2010-07-03,2011-08-10 16:16:39+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,126011000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q2,2010-04-04,2010-07-03,2011-08-10 16:16:39+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,126011000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q2,2010-04-04,2010-07-03,2011-08-10 16:16:39+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,22735000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q2,2010-04-04,2010-07-03,2011-08-10 16:16:39+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,22735000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q2,2010-04-04,2010-07-03,2011-08-10 16:16:39+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,103276000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q2,2010-04-04,2010-07-03,2011-08-10 16:16:39+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,29149000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q2,2010-04-04,2010-07-03,2011-08-10 16:16:39+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,57065000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q2,2010-04-04,2010-07-03,2011-08-10 16:16:39+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,86214000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q2,2010-04-04,2010-07-03,2011-08-10 16:16:39+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,17062000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q2,2010-04-04,2010-07-03,2011-08-10 16:16:39+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q2,2010-04-04,2010-07-03,2011-08-10 16:16:39+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,16000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q2,2010-04-04,2010-07-03,2011-08-10 16:16:39+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-598000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q2,2010-04-04,2010-07-03,2011-08-10 16:16:39+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-587000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q2,2010-04-04,2010-07-03,2011-08-10 16:16:39+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,16475000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q2,2010-04-04,2010-07-03,2011-08-10 16:16:39+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5705000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q2,2010-04-04,2010-07-03,2011-08-10 16:16:39+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10770000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q2,2010-04-04,2010-07-03,2011-08-10 16:16:39+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,10770000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q2,2010-04-04,2010-07-03,2011-08-10 16:16:39+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,10770000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q2,2010-04-04,2010-07-03,2011-08-10 16:16:39+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,15318000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q2,2010-04-04,2010-07-03,2011-08-10 16:16:39+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.7
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q2,2010-04-04,2010-07-03,2011-08-10 16:16:39+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15697000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q2,2010-04-04,2010-07-03,2011-08-10 16:16:39+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.69
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q2,2010-04-04,2010-07-03,2011-08-10 16:16:39+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,15400000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q2,2010-04-04,2010-07-03,2011-08-10 16:16:39+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.7
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q3,2010-07-04,2010-10-02,2011-11-09 16:20:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,135006000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q3,2010-07-04,2010-10-02,2011-11-09 16:20:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,135006000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q3,2010-07-04,2010-10-02,2011-11-09 16:20:14+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,25157000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q3,2010-07-04,2010-10-02,2011-11-09 16:20:14+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,25157000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q3,2010-07-04,2010-10-02,2011-11-09 16:20:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,109849000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q3,2010-07-04,2010-10-02,2011-11-09 16:20:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,30751000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q3,2010-07-04,2010-10-02,2011-11-09 16:20:14+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,60560000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q3,2010-07-04,2010-10-02,2011-11-09 16:20:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,91311000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q3,2010-07-04,2010-10-02,2011-11-09 16:20:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,18538000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q3,2010-07-04,2010-10-02,2011-11-09 16:20:14+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,42000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q3,2010-07-04,2010-10-02,2011-11-09 16:20:14+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,36000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q3,2010-07-04,2010-10-02,2011-11-09 16:20:14+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,557000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q3,2010-07-04,2010-10-02,2011-11-09 16:20:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,551000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q3,2010-07-04,2010-10-02,2011-11-09 16:20:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,19089000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q3,2010-07-04,2010-10-02,2011-11-09 16:20:14+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6240000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q3,2010-07-04,2010-10-02,2011-11-09 16:20:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12849000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q3,2010-07-04,2010-10-02,2011-11-09 16:20:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,12849000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q3,2010-07-04,2010-10-02,2011-11-09 16:20:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,12849000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q3,2010-07-04,2010-10-02,2011-11-09 16:20:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,15562000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q3,2010-07-04,2010-10-02,2011-11-09 16:20:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.83
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q3,2010-07-04,2010-10-02,2011-11-09 16:20:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,16247000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q3,2010-07-04,2010-10-02,2011-11-09 16:20:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.79
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q3,2010-07-04,2010-10-02,2011-11-09 16:20:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,15500000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2010.0,Q3,2010-07-04,2010-10-02,2011-11-09 16:20:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.83
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q1,2011-01-02,2011-04-02,2012-05-10 15:06:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,143566000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q1,2011-01-02,2011-04-02,2012-05-10 15:06:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,143566000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q1,2011-01-02,2011-04-02,2012-05-10 15:06:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,25662000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q1,2011-01-02,2011-04-02,2012-05-10 15:06:11+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,25662000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q1,2011-01-02,2011-04-02,2012-05-10 15:06:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,117904000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q1,2011-01-02,2011-04-02,2012-05-10 15:06:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,35870000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q1,2011-01-02,2011-04-02,2012-05-10 15:06:11+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,64807000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q1,2011-01-02,2011-04-02,2012-05-10 15:06:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,100677000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q1,2011-01-02,2011-04-02,2012-05-10 15:06:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,17227000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q1,2011-01-02,2011-04-02,2012-05-10 15:06:11+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q1,2011-01-02,2011-04-02,2012-05-10 15:06:11+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,50000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q1,2011-01-02,2011-04-02,2012-05-10 15:06:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,57000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q1,2011-01-02,2011-04-02,2012-05-10 15:06:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,101000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q1,2011-01-02,2011-04-02,2012-05-10 15:06:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,17328000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q1,2011-01-02,2011-04-02,2012-05-10 15:06:11+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5978000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q1,2011-01-02,2011-04-02,2012-05-10 15:06:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11350000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q1,2011-01-02,2011-04-02,2012-05-10 15:06:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,11350000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q1,2011-01-02,2011-04-02,2012-05-10 15:06:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,11350000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q1,2011-01-02,2011-04-02,2012-05-10 15:06:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,15911000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q1,2011-01-02,2011-04-02,2012-05-10 15:06:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.71
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q1,2011-01-02,2011-04-02,2012-05-10 15:06:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,16217000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q1,2011-01-02,2011-04-02,2012-05-10 15:06:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.7
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q1,2011-01-02,2011-04-02,2012-05-10 15:06:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,16000000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q1,2011-01-02,2011-04-02,2012-05-10 15:06:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.71
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q2,2011-04-03,2011-07-02,2012-08-08 15:23:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,148925000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q2,2011-04-03,2011-07-02,2012-08-08 15:23:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,148925000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q2,2011-04-03,2011-07-02,2012-08-08 15:23:15+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,26208000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q2,2011-04-03,2011-07-02,2012-08-08 15:23:15+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,26208000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q2,2011-04-03,2011-07-02,2012-08-08 15:23:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,122717000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q2,2011-04-03,2011-07-02,2012-08-08 15:23:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,33803000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q2,2011-04-03,2011-07-02,2012-08-08 15:23:15+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,67760000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q2,2011-04-03,2011-07-02,2012-08-08 15:23:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,101563000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q2,2011-04-03,2011-07-02,2012-08-08 15:23:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,21154000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q2,2011-04-03,2011-07-02,2012-08-08 15:23:15+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q2,2011-04-03,2011-07-02,2012-08-08 15:23:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,54000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q2,2011-04-03,2011-07-02,2012-08-08 15:23:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-52000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q2,2011-04-03,2011-07-02,2012-08-08 15:23:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,21154000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q2,2011-04-03,2011-07-02,2012-08-08 15:23:15+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7298000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q2,2011-04-03,2011-07-02,2012-08-08 15:23:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,13856000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q2,2011-04-03,2011-07-02,2012-08-08 15:23:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,13856000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q2,2011-04-03,2011-07-02,2012-08-08 15:23:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,13856000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q2,2011-04-03,2011-07-02,2012-08-08 15:23:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,15530000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q2,2011-04-03,2011-07-02,2012-08-08 15:23:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.89
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q2,2011-04-03,2011-07-02,2012-08-08 15:23:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15752000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q2,2011-04-03,2011-07-02,2012-08-08 15:23:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.88
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q2,2011-04-03,2011-07-02,2012-08-08 15:23:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,15600000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q2,2011-04-03,2011-07-02,2012-08-08 15:23:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.89
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q3,2011-07-03,2011-10-01,2012-11-07 15:17:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,143501000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q3,2011-07-03,2011-10-01,2012-11-07 15:17:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,143501000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q3,2011-07-03,2011-10-01,2012-11-07 15:17:03+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,25202000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q3,2011-07-03,2011-10-01,2012-11-07 15:17:03+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,25202000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q3,2011-07-03,2011-10-01,2012-11-07 15:17:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,118299000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q3,2011-07-03,2011-10-01,2012-11-07 15:17:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,33365000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q3,2011-07-03,2011-10-01,2012-11-07 15:17:03+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,66158000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q3,2011-07-03,2011-10-01,2012-11-07 15:17:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,99523000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q3,2011-07-03,2011-10-01,2012-11-07 15:17:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,18776000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q3,2011-07-03,2011-10-01,2012-11-07 15:17:03+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q3,2011-07-03,2011-10-01,2012-11-07 15:17:03+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,42000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q3,2011-07-03,2011-10-01,2012-11-07 15:17:03+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,92000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q3,2011-07-03,2011-10-01,2012-11-07 15:17:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,133000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q3,2011-07-03,2011-10-01,2012-11-07 15:17:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,18909000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q3,2011-07-03,2011-10-01,2012-11-07 15:17:03+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6524000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q3,2011-07-03,2011-10-01,2012-11-07 15:17:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12385000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q3,2011-07-03,2011-10-01,2012-11-07 15:17:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,12385000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q3,2011-07-03,2011-10-01,2012-11-07 15:17:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,12385000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q3,2011-07-03,2011-10-01,2012-11-07 15:17:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,15043000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q3,2011-07-03,2011-10-01,2012-11-07 15:17:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.82
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q3,2011-07-03,2011-10-01,2012-11-07 15:17:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15205000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q3,2011-07-03,2011-10-01,2012-11-07 15:17:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.81
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q3,2011-07-03,2011-10-01,2012-11-07 15:17:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,15100000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q3,2011-07-03,2011-10-01,2012-11-07 15:17:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.82
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q4,2011-10-02,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,145947000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q4,2011-10-02,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,145947000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q4,2011-10-02,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,24620000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q4,2011-10-02,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,24620000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q4,2011-10-02,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,121327000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q4,2011-10-02,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,34025000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q4,2011-10-02,2011-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,67203000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q4,2011-10-02,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,101228000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q4,2011-10-02,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,20099000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q4,2011-10-02,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,45000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q4,2011-10-02,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-57000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q4,2011-10-02,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-12000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q4,2011-10-02,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,20087000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q4,2011-10-02,2011-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6926000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q4,2011-10-02,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,13161000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q4,2011-10-02,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,13161000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q4,2011-10-02,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,13161000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q4,2011-10-02,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,15361000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q4,2011-10-02,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.88
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q4,2011-10-02,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15574000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q4,2011-10-02,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.87
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q4,2011-10-02,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,15400000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2011.0,Q4,2011-10-02,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.88
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:01:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,154120000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:01:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,154120000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:01:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,27217000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:01:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,27217000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:01:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,126903000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:01:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,38032000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:01:42+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,68009000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:01:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,106041000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:01:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,20862000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:01:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,38000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:01:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,94000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:01:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,132000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:01:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,20994000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:01:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7243000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:01:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,13751000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:01:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,13751000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:01:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,13751000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:01:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,14964000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:01:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.92
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:01:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15288000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:01:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.9
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:01:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14900000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 17:01:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.92
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 12:58:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,160901000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 12:58:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,160901000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 12:58:26+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,28073000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 12:58:26+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,28073000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 12:58:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,132828000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 12:58:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,36776000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 12:58:26+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,70901000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 12:58:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,107677000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 12:58:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,25151000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 12:58:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,71000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 12:58:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-293000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 12:58:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-222000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 12:58:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,24929000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 12:58:26+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8184000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 12:58:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,16745000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 12:58:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,16745000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 12:58:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,16745000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 12:58:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,14691000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 12:58:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.14
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 12:58:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15090000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 12:58:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.11
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 12:58:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14700000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 12:58:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.14
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q3,2012-07-01,2012-09-29,2013-11-07 14:22:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,165175000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q3,2012-07-01,2012-09-29,2013-11-07 14:22:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,165175000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q3,2012-07-01,2012-09-29,2013-11-07 14:22:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,30343000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q3,2012-07-01,2012-09-29,2013-11-07 14:22:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,30343000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q3,2012-07-01,2012-09-29,2013-11-07 14:22:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,134832000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q3,2012-07-01,2012-09-29,2013-11-07 14:22:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,40342000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q3,2012-07-01,2012-09-29,2013-11-07 14:22:34+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,70406000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q3,2012-07-01,2012-09-29,2013-11-07 14:22:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,110748000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q3,2012-07-01,2012-09-29,2013-11-07 14:22:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,24084000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q3,2012-07-01,2012-09-29,2013-11-07 14:22:34+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,64000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q3,2012-07-01,2012-09-29,2013-11-07 14:22:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,203000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q3,2012-07-01,2012-09-29,2013-11-07 14:22:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,267000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q3,2012-07-01,2012-09-29,2013-11-07 14:22:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,24351000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q3,2012-07-01,2012-09-29,2013-11-07 14:22:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6861000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q3,2012-07-01,2012-09-29,2013-11-07 14:22:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,17490000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q3,2012-07-01,2012-09-29,2013-11-07 14:22:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,17490000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q3,2012-07-01,2012-09-29,2013-11-07 14:22:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,17490000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q3,2012-07-01,2012-09-29,2013-11-07 14:22:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,14365000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q3,2012-07-01,2012-09-29,2013-11-07 14:22:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.22
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q3,2012-07-01,2012-09-29,2013-11-07 14:22:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,14884000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q3,2012-07-01,2012-09-29,2013-11-07 14:22:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.18
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q3,2012-07-01,2012-09-29,2013-11-07 14:22:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14300000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q3,2012-07-01,2012-09-29,2013-11-07 14:22:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.22
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q4,2012-09-30,2012-12-29,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,168530000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q4,2012-09-30,2012-12-29,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,168530000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q4,2012-09-30,2012-12-29,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,30171000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q4,2012-09-30,2012-12-29,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,30171000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q4,2012-09-30,2012-12-29,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,138359000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q4,2012-09-30,2012-12-29,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,39087000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q4,2012-09-30,2012-12-29,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,71190000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q4,2012-09-30,2012-12-29,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,110277000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q4,2012-09-30,2012-12-29,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,28082000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q4,2012-09-30,2012-12-29,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,20000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q4,2012-09-30,2012-12-29,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,74000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q4,2012-09-30,2012-12-29,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,16000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q4,2012-09-30,2012-12-29,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,70000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q4,2012-09-30,2012-12-29,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,28152000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q4,2012-09-30,2012-12-29,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,9705000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q4,2012-09-30,2012-12-29,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,18447000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q4,2012-09-30,2012-12-29,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,18447000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q4,2012-09-30,2012-12-29,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,18447000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q4,2012-09-30,2012-12-29,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,14547000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q4,2012-09-30,2012-12-29,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.29
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q4,2012-09-30,2012-12-29,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,14923000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q4,2012-09-30,2012-12-29,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.26
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q4,2012-09-30,2012-12-29,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14500000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2012.0,Q4,2012-09-30,2012-12-29,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.29
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q1,2012-12-30,2013-03-30,2014-05-07 17:24:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,169082000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q1,2012-12-30,2013-03-30,2014-05-07 17:24:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,169082000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q1,2012-12-30,2013-03-30,2014-05-07 17:24:50+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,30261000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q1,2012-12-30,2013-03-30,2014-05-07 17:24:50+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,30261000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q1,2012-12-30,2013-03-30,2014-05-07 17:24:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,138821000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q1,2012-12-30,2013-03-30,2014-05-07 17:24:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,42404000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q1,2012-12-30,2013-03-30,2014-05-07 17:24:50+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,69855000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q1,2012-12-30,2013-03-30,2014-05-07 17:24:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,112259000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q1,2012-12-30,2013-03-30,2014-05-07 17:24:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,26562000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q1,2012-12-30,2013-03-30,2014-05-07 17:24:50+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,78000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q1,2012-12-30,2013-03-30,2014-05-07 17:24:50+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-104000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q1,2012-12-30,2013-03-30,2014-05-07 17:24:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-26000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q1,2012-12-30,2013-03-30,2014-05-07 17:24:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,26536000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q1,2012-12-30,2013-03-30,2014-05-07 17:24:50+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8757000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q1,2012-12-30,2013-03-30,2014-05-07 17:24:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,17779000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q1,2012-12-30,2013-03-30,2014-05-07 17:24:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,17779000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q1,2012-12-30,2013-03-30,2014-05-07 17:24:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,17779000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q1,2012-12-30,2013-03-30,2014-05-07 17:24:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,13643000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q1,2012-12-30,2013-03-30,2014-05-07 17:24:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.3
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q1,2012-12-30,2013-03-30,2014-05-07 17:24:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,13903000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q1,2012-12-30,2013-03-30,2014-05-07 17:24:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.28
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q1,2012-12-30,2013-03-30,2014-05-07 17:24:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13700000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q1,2012-12-30,2013-03-30,2014-05-07 17:24:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.3
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q2,2013-03-31,2013-06-29,2014-08-05 13:37:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,189136000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q2,2013-03-31,2013-06-29,2014-08-05 13:37:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,189136000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q2,2013-03-31,2013-06-29,2014-08-05 13:37:51+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,31905000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q2,2013-03-31,2013-06-29,2014-08-05 13:37:51+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,31905000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q2,2013-03-31,2013-06-29,2014-08-05 13:37:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,157231000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q2,2013-03-31,2013-06-29,2014-08-05 13:37:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,42978000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q2,2013-03-31,2013-06-29,2014-08-05 13:37:51+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,77801000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q2,2013-03-31,2013-06-29,2014-08-05 13:37:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,120779000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q2,2013-03-31,2013-06-29,2014-08-05 13:37:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,36452000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q2,2013-03-31,2013-06-29,2014-08-05 13:37:51+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,81000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q2,2013-03-31,2013-06-29,2014-08-05 13:37:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-164000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q2,2013-03-31,2013-06-29,2014-08-05 13:37:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-83000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q2,2013-03-31,2013-06-29,2014-08-05 13:37:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,36369000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q2,2013-03-31,2013-06-29,2014-08-05 13:37:51+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,12159000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q2,2013-03-31,2013-06-29,2014-08-05 13:37:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,24210000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q2,2013-03-31,2013-06-29,2014-08-05 13:37:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,24210000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q2,2013-03-31,2013-06-29,2014-08-05 13:37:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,24210000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q2,2013-03-31,2013-06-29,2014-08-05 13:37:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,13513000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q2,2013-03-31,2013-06-29,2014-08-05 13:37:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.79
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q2,2013-03-31,2013-06-29,2014-08-05 13:37:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,14099000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q2,2013-03-31,2013-06-29,2014-08-05 13:37:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.72
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q2,2013-03-31,2013-06-29,2014-08-05 13:37:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13500000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q2,2013-03-31,2013-06-29,2014-08-05 13:37:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.79
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q3,2013-06-30,2013-09-28,2014-11-06 15:13:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,173691000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q3,2013-06-30,2013-09-28,2014-11-06 15:13:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,173691000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q3,2013-06-30,2013-09-28,2014-11-06 15:13:26+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,31491000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q3,2013-06-30,2013-09-28,2014-11-06 15:13:26+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,31491000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q3,2013-06-30,2013-09-28,2014-11-06 15:13:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,142200000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q3,2013-06-30,2013-09-28,2014-11-06 15:13:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,41145000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q3,2013-06-30,2013-09-28,2014-11-06 15:13:26+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,76361000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q3,2013-06-30,2013-09-28,2014-11-06 15:13:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,117506000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q3,2013-06-30,2013-09-28,2014-11-06 15:13:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,24694000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q3,2013-06-30,2013-09-28,2014-11-06 15:13:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,119000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q3,2013-06-30,2013-09-28,2014-11-06 15:13:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-43000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q3,2013-06-30,2013-09-28,2014-11-06 15:13:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,76000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q3,2013-06-30,2013-09-28,2014-11-06 15:13:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,24770000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q3,2013-06-30,2013-09-28,2014-11-06 15:13:26+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8017000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q3,2013-06-30,2013-09-28,2014-11-06 15:13:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,16753000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q3,2013-06-30,2013-09-28,2014-11-06 15:13:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,16753000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q3,2013-06-30,2013-09-28,2014-11-06 15:13:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,16753000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q3,2013-06-30,2013-09-28,2014-11-06 15:13:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,13751000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q3,2013-06-30,2013-09-28,2014-11-06 15:13:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.22
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q3,2013-06-30,2013-09-28,2014-11-06 15:13:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,14393000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q3,2013-06-30,2013-09-28,2014-11-06 15:13:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.16
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q3,2013-06-30,2013-09-28,2014-11-06 15:13:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13700000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q3,2013-06-30,2013-09-28,2014-11-06 15:13:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.22
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q4,2013-09-29,2013-12-28,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,186266000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q4,2013-09-29,2013-12-28,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,186266000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q4,2013-09-29,2013-12-28,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,33778000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q4,2013-09-29,2013-12-28,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,33778000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q4,2013-09-29,2013-12-28,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,152488000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q4,2013-09-29,2013-12-28,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,39681000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q4,2013-09-29,2013-12-28,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,83803000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q4,2013-09-29,2013-12-28,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,123484000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q4,2013-09-29,2013-12-28,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,29004000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q4,2013-09-29,2013-12-28,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q4,2013-09-29,2013-12-28,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,186000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q4,2013-09-29,2013-12-28,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-283000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q4,2013-09-29,2013-12-28,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-98000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q4,2013-09-29,2013-12-28,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,28906000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q4,2013-09-29,2013-12-28,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8624000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q4,2013-09-29,2013-12-28,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,20282000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q4,2013-09-29,2013-12-28,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,20282000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q4,2013-09-29,2013-12-28,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,20282000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q4,2013-09-29,2013-12-28,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,13695000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q4,2013-09-29,2013-12-28,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.48
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q4,2013-09-29,2013-12-28,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,14204000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q4,2013-09-29,2013-12-28,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.48
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q4,2013-09-29,2013-12-28,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13700000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2013.0,Q4,2013-09-29,2013-12-28,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.48
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q1,2013-12-29,2014-03-29,2015-05-13 15:09:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,182401000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q1,2013-12-29,2014-03-29,2015-05-13 15:09:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,182401000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q1,2013-12-29,2014-03-29,2015-05-13 15:09:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,33828000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q1,2013-12-29,2014-03-29,2015-05-13 15:09:33+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,33828000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q1,2013-12-29,2014-03-29,2015-05-13 15:09:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,148573000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q1,2013-12-29,2014-03-29,2015-05-13 15:09:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,44577000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q1,2013-12-29,2014-03-29,2015-05-13 15:09:33+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,78874000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q1,2013-12-29,2014-03-29,2015-05-13 15:09:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,123451000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q1,2013-12-29,2014-03-29,2015-05-13 15:09:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,25122000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q1,2013-12-29,2014-03-29,2015-05-13 15:09:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q1,2013-12-29,2014-03-29,2015-05-13 15:09:33+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,212000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q1,2013-12-29,2014-03-29,2015-05-13 15:09:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-81000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q1,2013-12-29,2014-03-29,2015-05-13 15:09:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,125000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q1,2013-12-29,2014-03-29,2015-05-13 15:09:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,25247000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q1,2013-12-29,2014-03-29,2015-05-13 15:09:33+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8710000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q1,2013-12-29,2014-03-29,2015-05-13 15:09:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,16537000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q1,2013-12-29,2014-03-29,2015-05-13 15:09:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,16537000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q1,2013-12-29,2014-03-29,2015-05-13 15:09:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,16537000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q1,2013-12-29,2014-03-29,2015-05-13 15:09:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,13919000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q1,2013-12-29,2014-03-29,2015-05-13 15:09:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.19
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q1,2013-12-29,2014-03-29,2015-05-13 15:09:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,14395000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q1,2013-12-29,2014-03-29,2015-05-13 15:09:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.15
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q1,2013-12-29,2014-03-29,2015-05-13 15:09:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13900000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q1,2013-12-29,2014-03-29,2015-05-13 15:09:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.19
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q2,2014-03-30,2014-06-28,2015-08-12 15:02:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,188256000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q2,2014-03-30,2014-06-28,2015-08-12 15:02:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,188256000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q2,2014-03-30,2014-06-28,2015-08-12 15:02:15+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,34865000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q2,2014-03-30,2014-06-28,2015-08-12 15:02:15+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,34865000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q2,2014-03-30,2014-06-28,2015-08-12 15:02:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,153391000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q2,2014-03-30,2014-06-28,2015-08-12 15:02:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,43206000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q2,2014-03-30,2014-06-28,2015-08-12 15:02:15+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,81098000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q2,2014-03-30,2014-06-28,2015-08-12 15:02:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,124304000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q2,2014-03-30,2014-06-28,2015-08-12 15:02:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,29087000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q2,2014-03-30,2014-06-28,2015-08-12 15:02:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,215000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q2,2014-03-30,2014-06-28,2015-08-12 15:02:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,82000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q2,2014-03-30,2014-06-28,2015-08-12 15:02:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,297000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q2,2014-03-30,2014-06-28,2015-08-12 15:02:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,29384000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q2,2014-03-30,2014-06-28,2015-08-12 15:02:15+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10083000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q2,2014-03-30,2014-06-28,2015-08-12 15:02:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,19301000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q2,2014-03-30,2014-06-28,2015-08-12 15:02:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,19301000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q2,2014-03-30,2014-06-28,2015-08-12 15:02:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,19301000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q2,2014-03-30,2014-06-28,2015-08-12 15:02:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,13768000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q2,2014-03-30,2014-06-28,2015-08-12 15:02:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.4
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q2,2014-03-30,2014-06-28,2015-08-12 15:02:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,14235000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q2,2014-03-30,2014-06-28,2015-08-12 15:02:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.36
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q2,2014-03-30,2014-06-28,2015-08-12 15:02:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13800000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q2,2014-03-30,2014-06-28,2015-08-12 15:02:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.4
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q3,2014-06-29,2014-09-27,2015-11-12 13:57:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,191944000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q3,2014-06-29,2014-09-27,2015-11-12 13:57:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,191944000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q3,2014-06-29,2014-09-27,2015-11-12 13:57:44+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,34585000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q3,2014-06-29,2014-09-27,2015-11-12 13:57:44+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,34585000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q3,2014-06-29,2014-09-27,2015-11-12 13:57:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,157359000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q3,2014-06-29,2014-09-27,2015-11-12 13:57:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,45499000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q3,2014-06-29,2014-09-27,2015-11-12 13:57:44+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,82605000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q3,2014-06-29,2014-09-27,2015-11-12 13:57:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,128104000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q3,2014-06-29,2014-09-27,2015-11-12 13:57:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,29255000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q3,2014-06-29,2014-09-27,2015-11-12 13:57:44+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q3,2014-06-29,2014-09-27,2015-11-12 13:57:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q3,2014-06-29,2014-09-27,2015-11-12 13:57:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-300000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q3,2014-06-29,2014-09-27,2015-11-12 13:57:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-297000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q3,2014-06-29,2014-09-27,2015-11-12 13:57:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,28958000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q3,2014-06-29,2014-09-27,2015-11-12 13:57:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,9460000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q3,2014-06-29,2014-09-27,2015-11-12 13:57:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,19498000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q3,2014-06-29,2014-09-27,2015-11-12 13:57:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,19498000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q3,2014-06-29,2014-09-27,2015-11-12 13:57:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,19498000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q3,2014-06-29,2014-09-27,2015-11-12 13:57:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,12873000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q3,2014-06-29,2014-09-27,2015-11-12 13:57:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.51
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q3,2014-06-29,2014-09-27,2015-11-12 13:57:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,13263000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q3,2014-06-29,2014-09-27,2015-11-12 13:57:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.47
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q3,2014-06-29,2014-09-27,2015-11-12 13:57:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,12900000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q3,2014-06-29,2014-09-27,2015-11-12 13:57:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.51
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q4,2014-09-28,2015-01-03,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,227870000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q4,2014-09-28,2015-01-03,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,227870000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q4,2014-09-28,2015-01-03,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,37516000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q4,2014-09-28,2015-01-03,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,37516000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q4,2014-09-28,2015-01-03,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,190354000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q4,2014-09-28,2015-01-03,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,51249000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q4,2014-09-28,2015-01-03,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,106467000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q4,2014-09-28,2015-01-03,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,157716000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q4,2014-09-28,2015-01-03,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,32638000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q4,2014-09-28,2015-01-03,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,118000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q4,2014-09-28,2015-01-03,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,65000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q4,2014-09-28,2015-01-03,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-521000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q4,2014-09-28,2015-01-03,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-574000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q4,2014-09-28,2015-01-03,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,32064000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q4,2014-09-28,2015-01-03,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10764000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q4,2014-09-28,2015-01-03,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,21300000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q4,2014-09-28,2015-01-03,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,21300000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q4,2014-09-28,2015-01-03,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,21300000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q4,2014-09-28,2015-01-03,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,26443000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q4,2014-09-28,2015-01-03,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.81
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q4,2014-09-28,2015-01-03,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27377000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q4,2014-09-28,2015-01-03,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.81
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q4,2014-09-28,2015-01-03,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,26400000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2014.0,Q4,2014-09-28,2015-01-03,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.81
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q1,2015-01-04,2015-04-04,2016-05-11 15:05:37+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,219378000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q1,2015-01-04,2015-04-04,2016-05-11 15:05:37+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,219378000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q1,2015-01-04,2015-04-04,2016-05-11 15:05:37+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,38364000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q1,2015-01-04,2015-04-04,2016-05-11 15:05:37+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,38364000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q1,2015-01-04,2015-04-04,2016-05-11 15:05:37+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,181014000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q1,2015-01-04,2015-04-04,2016-05-11 15:05:37+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,49875000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q1,2015-01-04,2015-04-04,2016-05-11 15:05:37+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,101353000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q1,2015-01-04,2015-04-04,2016-05-11 15:05:37+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,151228000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q1,2015-01-04,2015-04-04,2016-05-11 15:05:37+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,29786000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q1,2015-01-04,2015-04-04,2016-05-11 15:05:37+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,154000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q1,2015-01-04,2015-04-04,2016-05-11 15:05:37+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,14000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q1,2015-01-04,2015-04-04,2016-05-11 15:05:37+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,168000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q1,2015-01-04,2015-04-04,2016-05-11 15:05:37+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,29954000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q1,2015-01-04,2015-04-04,2016-05-11 15:05:37+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10274000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q1,2015-01-04,2015-04-04,2016-05-11 15:05:37+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,19680000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q1,2015-01-04,2015-04-04,2016-05-11 15:05:37+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,19680000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q1,2015-01-04,2015-04-04,2016-05-11 15:05:37+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,19680000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q1,2015-01-04,2015-04-04,2016-05-11 15:05:37+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,12648000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q1,2015-01-04,2015-04-04,2016-05-11 15:05:37+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.56
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q1,2015-01-04,2015-04-04,2016-05-11 15:05:37+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,13085000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q1,2015-01-04,2015-04-04,2016-05-11 15:05:37+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.5
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q1,2015-01-04,2015-04-04,2016-05-11 15:05:37+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,12600000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q1,2015-01-04,2015-04-04,2016-05-11 15:05:37+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.56
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q2,2015-04-05,2015-07-04,2016-08-09 11:53:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,233244000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q2,2015-04-05,2015-07-04,2016-08-09 11:53:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,233244000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q2,2015-04-05,2015-07-04,2016-08-09 11:53:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,40089000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q2,2015-04-05,2015-07-04,2016-08-09 11:53:11+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,40089000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q2,2015-04-05,2015-07-04,2016-08-09 11:53:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,193155000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q2,2015-04-05,2015-07-04,2016-08-09 11:53:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,52505000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q2,2015-04-05,2015-07-04,2016-08-09 11:53:11+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,101877000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q2,2015-04-05,2015-07-04,2016-08-09 11:53:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,154382000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q2,2015-04-05,2015-07-04,2016-08-09 11:53:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,38773000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q2,2015-04-05,2015-07-04,2016-08-09 11:53:11+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q2,2015-04-05,2015-07-04,2016-08-09 11:53:11+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,232000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q2,2015-04-05,2015-07-04,2016-08-09 11:53:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-311000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q2,2015-04-05,2015-07-04,2016-08-09 11:53:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-86000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q2,2015-04-05,2015-07-04,2016-08-09 11:53:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,38687000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q2,2015-04-05,2015-07-04,2016-08-09 11:53:11+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,13271000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q2,2015-04-05,2015-07-04,2016-08-09 11:53:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,25416000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q2,2015-04-05,2015-07-04,2016-08-09 11:53:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,25416000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q2,2015-04-05,2015-07-04,2016-08-09 11:53:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,25416000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q2,2015-04-05,2015-07-04,2016-08-09 11:53:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,12740000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q2,2015-04-05,2015-07-04,2016-08-09 11:53:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.99
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q2,2015-04-05,2015-07-04,2016-08-09 11:53:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,13225000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q2,2015-04-05,2015-07-04,2016-08-09 11:53:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.92
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q2,2015-04-05,2015-07-04,2016-08-09 11:53:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,12800000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q2,2015-04-05,2015-07-04,2016-08-09 11:53:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.99
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q3,2015-07-05,2015-10-03,2016-11-09 13:55:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,233292000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q3,2015-07-05,2015-10-03,2016-11-09 13:55:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,233292000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q3,2015-07-05,2015-10-03,2016-11-09 13:55:45+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,41048000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q3,2015-07-05,2015-10-03,2016-11-09 13:55:45+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,41048000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q3,2015-07-05,2015-10-03,2016-11-09 13:55:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,192244000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q3,2015-07-05,2015-10-03,2016-11-09 13:55:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,52757000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q3,2015-07-05,2015-10-03,2016-11-09 13:55:45+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,101521000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q3,2015-07-05,2015-10-03,2016-11-09 13:55:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,154278000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q3,2015-07-05,2015-10-03,2016-11-09 13:55:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,37966000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q3,2015-07-05,2015-10-03,2016-11-09 13:55:45+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q3,2015-07-05,2015-10-03,2016-11-09 13:55:45+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,367000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q3,2015-07-05,2015-10-03,2016-11-09 13:55:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,78000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q3,2015-07-05,2015-10-03,2016-11-09 13:55:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,441000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q3,2015-07-05,2015-10-03,2016-11-09 13:55:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,38407000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q3,2015-07-05,2015-10-03,2016-11-09 13:55:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,12798000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q3,2015-07-05,2015-10-03,2016-11-09 13:55:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,25609000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q3,2015-07-05,2015-10-03,2016-11-09 13:55:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,25609000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q3,2015-07-05,2015-10-03,2016-11-09 13:55:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,25609000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q3,2015-07-05,2015-10-03,2016-11-09 13:55:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,12852000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q3,2015-07-05,2015-10-03,2016-11-09 13:55:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.99
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q3,2015-07-05,2015-10-03,2016-11-09 13:55:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,13317000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q3,2015-07-05,2015-10-03,2016-11-09 13:55:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.92
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q3,2015-07-05,2015-10-03,2016-11-09 13:55:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,12900000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q3,2015-07-05,2015-10-03,2016-11-09 13:55:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.99
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q4,2015-10-04,2016-01-02,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,232585000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q4,2015-10-04,2016-01-02,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,232585000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q4,2015-10-04,2016-01-02,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,40181000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q4,2015-10-04,2016-01-02,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,40181000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q4,2015-10-04,2016-01-02,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,192404000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q4,2015-10-04,2016-01-02,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,53858000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q4,2015-10-04,2016-01-02,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,103409000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q4,2015-10-04,2016-01-02,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,157267000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q4,2015-10-04,2016-01-02,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,35137000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q4,2015-10-04,2016-01-02,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q4,2015-10-04,2016-01-02,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,363000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q4,2015-10-04,2016-01-02,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,45000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q4,2015-10-04,2016-01-02,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,404000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q4,2015-10-04,2016-01-02,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,35541000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q4,2015-10-04,2016-01-02,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11574000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q4,2015-10-04,2016-01-02,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,23967000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q4,2015-10-04,2016-01-02,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,23967000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q4,2015-10-04,2016-01-02,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,23967000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q4,2015-10-04,2016-01-02,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25460000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q4,2015-10-04,2016-01-02,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.94
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q4,2015-10-04,2016-01-02,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,26355000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q4,2015-10-04,2016-01-02,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.94
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q4,2015-10-04,2016-01-02,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25400000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2015.0,Q4,2015-10-04,2016-01-02,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.94
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q1,2016-01-03,2016-04-02,2017-05-10 13:32:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,240449000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q1,2016-01-03,2016-04-02,2017-05-10 13:32:02+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,240449000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q1,2016-01-03,2016-04-02,2017-05-10 13:32:02+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,42920000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q1,2016-01-03,2016-04-02,2017-05-10 13:32:02+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,42920000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q1,2016-01-03,2016-04-02,2017-05-10 13:32:02+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,197529000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q1,2016-01-03,2016-04-02,2017-05-10 13:32:02+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,56631000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q1,2016-01-03,2016-04-02,2017-05-10 13:32:02+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,107394000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q1,2016-01-03,2016-04-02,2017-05-10 13:32:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,164025000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q1,2016-01-03,2016-04-02,2017-05-10 13:32:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,33504000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q1,2016-01-03,2016-04-02,2017-05-10 13:32:02+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,202000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q1,2016-01-03,2016-04-02,2017-05-10 13:32:02+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,438000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q1,2016-01-03,2016-04-02,2017-05-10 13:32:02+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-732000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q1,2016-01-03,2016-04-02,2017-05-10 13:32:02+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-496000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q1,2016-01-03,2016-04-02,2017-05-10 13:32:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,33008000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q1,2016-01-03,2016-04-02,2017-05-10 13:32:02+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10709000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q1,2016-01-03,2016-04-02,2017-05-10 13:32:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,22299000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q1,2016-01-03,2016-04-02,2017-05-10 13:32:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,22299000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q1,2016-01-03,2016-04-02,2017-05-10 13:32:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,22299000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q1,2016-01-03,2016-04-02,2017-05-10 13:32:02+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24204000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q1,2016-01-03,2016-04-02,2017-05-10 13:32:02+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.92
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q1,2016-01-03,2016-04-02,2017-05-10 13:32:02+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25183000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q1,2016-01-03,2016-04-02,2017-05-10 13:32:02+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.89
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q1,2016-01-03,2016-04-02,2017-05-10 13:32:02+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24200000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q1,2016-01-03,2016-04-02,2017-05-10 13:32:02+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.92
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q2,2016-04-03,2016-07-02,2017-08-09 13:57:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,258514000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q2,2016-04-03,2016-07-02,2017-08-09 13:57:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,258514000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q2,2016-04-03,2016-07-02,2017-08-09 13:57:45+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,45970000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q2,2016-04-03,2016-07-02,2017-08-09 13:57:45+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,45970000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q2,2016-04-03,2016-07-02,2017-08-09 13:57:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,212544000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q2,2016-04-03,2016-07-02,2017-08-09 13:57:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,59764000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q2,2016-04-03,2016-07-02,2017-08-09 13:57:45+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,115331000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q2,2016-04-03,2016-07-02,2017-08-09 13:57:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,175095000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q2,2016-04-03,2016-07-02,2017-08-09 13:57:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,37449000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q2,2016-04-03,2016-07-02,2017-08-09 13:57:45+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,176000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q2,2016-04-03,2016-07-02,2017-08-09 13:57:45+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,323000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q2,2016-04-03,2016-07-02,2017-08-09 13:57:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,72000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q2,2016-04-03,2016-07-02,2017-08-09 13:57:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,219000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q2,2016-04-03,2016-07-02,2017-08-09 13:57:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,37668000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q2,2016-04-03,2016-07-02,2017-08-09 13:57:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11906000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q2,2016-04-03,2016-07-02,2017-08-09 13:57:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,25762000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q2,2016-04-03,2016-07-02,2017-08-09 13:57:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,25762000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q2,2016-04-03,2016-07-02,2017-08-09 13:57:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,25762000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q2,2016-04-03,2016-07-02,2017-08-09 13:57:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,23955000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q2,2016-04-03,2016-07-02,2017-08-09 13:57:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.08
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q2,2016-04-03,2016-07-02,2017-08-09 13:57:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24917000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q2,2016-04-03,2016-07-02,2017-08-09 13:57:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.03
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q2,2016-04-03,2016-07-02,2017-08-09 13:57:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,23900000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q2,2016-04-03,2016-07-02,2017-08-09 13:57:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.08
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q3,2016-07-03,2016-10-01,2017-11-08 13:34:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,254219000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q3,2016-07-03,2016-10-01,2017-11-08 13:34:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,254219000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q3,2016-07-03,2016-10-01,2017-11-08 13:34:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,44979000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q3,2016-07-03,2016-10-01,2017-11-08 13:34:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,44979000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q3,2016-07-03,2016-10-01,2017-11-08 13:34:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,209240000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q3,2016-07-03,2016-10-01,2017-11-08 13:34:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,60591000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q3,2016-07-03,2016-10-01,2017-11-08 13:34:47+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,112816000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q3,2016-07-03,2016-10-01,2017-11-08 13:34:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,173407000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q3,2016-07-03,2016-10-01,2017-11-08 13:34:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,35833000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q3,2016-07-03,2016-10-01,2017-11-08 13:34:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,46000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q3,2016-07-03,2016-10-01,2017-11-08 13:34:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,338000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q3,2016-07-03,2016-10-01,2017-11-08 13:34:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-24000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q3,2016-07-03,2016-10-01,2017-11-08 13:34:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,268000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q3,2016-07-03,2016-10-01,2017-11-08 13:34:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,36101000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q3,2016-07-03,2016-10-01,2017-11-08 13:34:47+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6003000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q3,2016-07-03,2016-10-01,2017-11-08 13:34:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,30098000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q3,2016-07-03,2016-10-01,2017-11-08 13:34:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,30098000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q3,2016-07-03,2016-10-01,2017-11-08 13:34:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,30098000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q3,2016-07-03,2016-10-01,2017-11-08 13:34:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24178000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q3,2016-07-03,2016-10-01,2017-11-08 13:34:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.24
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q3,2016-07-03,2016-10-01,2017-11-08 13:34:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25050000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q3,2016-07-03,2016-10-01,2017-11-08 13:34:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.2
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q3,2016-07-03,2016-10-01,2017-11-08 13:34:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24300000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q3,2016-07-03,2016-10-01,2017-11-08 13:34:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.24
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q4,2016-10-02,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,252901000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q4,2016-10-02,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,252901000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q4,2016-10-02,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,46321000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q4,2016-10-02,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,46321000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q4,2016-10-02,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,206580000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q4,2016-10-02,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,57208000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q4,2016-10-02,2016-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,117536000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q4,2016-10-02,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,174744000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q4,2016-10-02,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,31836000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q4,2016-10-02,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,20000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q4,2016-10-02,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,381000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q4,2016-10-02,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-422000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q4,2016-10-02,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-61000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q4,2016-10-02,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,31775000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q4,2016-10-02,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,9893000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q4,2016-10-02,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,21882000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q4,2016-10-02,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,21882000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q4,2016-10-02,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,21882000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q4,2016-10-02,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24185000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q4,2016-10-02,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.9
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q4,2016-10-02,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25047000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q4,2016-10-02,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.9
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q4,2016-10-02,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24200000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2016.0,Q4,2016-10-02,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.9
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q1,2017-01-01,2017-04-01,2018-05-09 13:42:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,255323000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q1,2017-01-01,2017-04-01,2018-05-09 13:42:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,255323000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q1,2017-01-01,2017-04-01,2018-05-09 13:42:14+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,42654000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q1,2017-01-01,2017-04-01,2018-05-09 13:42:14+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,42654000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q1,2017-01-01,2017-04-01,2018-05-09 13:42:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,212669000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q1,2017-01-01,2017-04-01,2018-05-09 13:42:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,64001000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q1,2017-01-01,2017-04-01,2018-05-09 13:42:14+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,115781000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q1,2017-01-01,2017-04-01,2018-05-09 13:42:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,179782000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q1,2017-01-01,2017-04-01,2018-05-09 13:42:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,32887000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q1,2017-01-01,2017-04-01,2018-05-09 13:42:14+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q1,2017-01-01,2017-04-01,2018-05-09 13:42:14+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,483000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q1,2017-01-01,2017-04-01,2018-05-09 13:42:14+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,9000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q1,2017-01-01,2017-04-01,2018-05-09 13:42:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,482000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q1,2017-01-01,2017-04-01,2018-05-09 13:42:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,33369000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q1,2017-01-01,2017-04-01,2018-05-09 13:42:14+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,12011000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q1,2017-01-01,2017-04-01,2018-05-09 13:42:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,21358000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q1,2017-01-01,2017-04-01,2018-05-09 13:42:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,21358000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q1,2017-01-01,2017-04-01,2018-05-09 13:42:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,21358000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q1,2017-01-01,2017-04-01,2018-05-09 13:42:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24499000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q1,2017-01-01,2017-04-01,2018-05-09 13:42:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.87
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q1,2017-01-01,2017-04-01,2018-05-09 13:42:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24976000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q1,2017-01-01,2017-04-01,2018-05-09 13:42:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.86
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q1,2017-01-01,2017-04-01,2018-05-09 13:42:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24500000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q1,2017-01-01,2017-04-01,2018-05-09 13:42:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.87
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 14:03:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,257063000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 14:03:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,257063000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 14:03:32+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,43902000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 14:03:32+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,43902000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 14:03:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,213161000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 14:03:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,62389000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 14:03:32+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,118404000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 14:03:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,180793000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 14:03:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,32368000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 14:03:32+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 14:03:32+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,590000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 14:03:32+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-119000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 14:03:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,460000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 14:03:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,32828000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 14:03:32+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,9569000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 14:03:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,23259000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 14:03:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,23259000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 14:03:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,23259000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 14:03:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24574000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 14:03:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.95
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 14:03:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25018000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 14:03:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.93
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 14:03:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24500000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 14:03:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.95
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q3,2017-07-02,2017-09-30,2018-11-07 15:13:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,261765000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q3,2017-07-02,2017-09-30,2018-11-07 15:13:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,261765000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q3,2017-07-02,2017-09-30,2018-11-07 15:13:28+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,47135000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q3,2017-07-02,2017-09-30,2018-11-07 15:13:28+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,47135000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q3,2017-07-02,2017-09-30,2018-11-07 15:13:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,214630000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q3,2017-07-02,2017-09-30,2018-11-07 15:13:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,67263000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q3,2017-07-02,2017-09-30,2018-11-07 15:13:28+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,116010000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q3,2017-07-02,2017-09-30,2018-11-07 15:13:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,183273000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q3,2017-07-02,2017-09-30,2018-11-07 15:13:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,31357000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q3,2017-07-02,2017-09-30,2018-11-07 15:13:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q3,2017-07-02,2017-09-30,2018-11-07 15:13:28+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,571000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q3,2017-07-02,2017-09-30,2018-11-07 15:13:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,129000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q3,2017-07-02,2017-09-30,2018-11-07 15:13:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,690000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q3,2017-07-02,2017-09-30,2018-11-07 15:13:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,32047000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q3,2017-07-02,2017-09-30,2018-11-07 15:13:28+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8278000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q3,2017-07-02,2017-09-30,2018-11-07 15:13:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,23769000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q3,2017-07-02,2017-09-30,2018-11-07 15:13:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,23769000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q3,2017-07-02,2017-09-30,2018-11-07 15:13:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,23769000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q3,2017-07-02,2017-09-30,2018-11-07 15:13:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24283000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q3,2017-07-02,2017-09-30,2018-11-07 15:13:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.98
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q3,2017-07-02,2017-09-30,2018-11-07 15:13:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24588000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q3,2017-07-02,2017-09-30,2018-11-07 15:13:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.97
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q3,2017-07-02,2017-09-30,2018-11-07 15:13:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24300000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q3,2017-07-02,2017-09-30,2018-11-07 15:13:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.98
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q4,2017-10-01,2017-12-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,273114000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q4,2017-10-01,2017-12-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,273114000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q4,2017-10-01,2017-12-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,45713000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q4,2017-10-01,2017-12-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,45713000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q4,2017-10-01,2017-12-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,227401000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q4,2017-10-01,2017-12-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,71441000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q4,2017-10-01,2017-12-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,120068000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q4,2017-10-01,2017-12-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,191509000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q4,2017-10-01,2017-12-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,35892000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q4,2017-10-01,2017-12-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,15000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q4,2017-10-01,2017-12-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,541000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q4,2017-10-01,2017-12-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-22000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q4,2017-10-01,2017-12-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,504000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q4,2017-10-01,2017-12-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,36396000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q4,2017-10-01,2017-12-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,42247000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q4,2017-10-01,2017-12-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5851000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q4,2017-10-01,2017-12-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5851000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q4,2017-10-01,2017-12-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5851000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q4,2017-10-01,2017-12-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24349000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q4,2017-10-01,2017-12-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.24
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q4,2017-10-01,2017-12-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24708000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q4,2017-10-01,2017-12-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.24
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q4,2017-10-01,2017-12-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24300000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2017.0,Q4,2017-10-01,2017-12-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.24
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 15:43:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,291998000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 15:43:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,291998000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 15:43:13+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,49375000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 15:43:13+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,49375000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 15:43:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,242623000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 15:43:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,70132000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 15:43:13+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,129362000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 15:43:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,199494000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 15:43:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,43129000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 15:43:13+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 15:43:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,840000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 15:43:13+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,32000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 15:43:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,862000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 15:43:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,43991000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 15:43:13+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,15045000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 15:43:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,28946000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 15:43:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,28946000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 15:43:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,28946000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 15:43:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24074000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 15:43:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.2
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 15:43:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24273000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 15:43:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.19
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 15:43:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24100000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 15:43:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.2
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 15:19:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,301460000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 15:19:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,301460000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 15:19:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,49991000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 15:19:11+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,49991000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 15:19:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,251469000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 15:19:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,67537000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 15:19:11+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,132790000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 15:19:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,200327000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 15:19:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,51142000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 15:19:11+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 15:19:11+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1031000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 15:19:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-634000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 15:19:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,388000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 15:19:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,51530000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 15:19:11+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,17623000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 15:19:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,33907000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 15:19:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,33907000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 15:19:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,33907000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 15:19:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24193000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 15:19:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.4
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 15:19:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24841000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 15:19:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.36
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 15:19:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24200000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 15:19:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.4
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q3,2018-07-01,2018-09-29,2019-11-05 14:03:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,296767000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q3,2018-07-01,2018-09-29,2019-11-05 14:03:09+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,296767000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q3,2018-07-01,2018-09-29,2019-11-05 14:03:09+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,51877000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q3,2018-07-01,2018-09-29,2019-11-05 14:03:09+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,51877000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q3,2018-07-01,2018-09-29,2019-11-05 14:03:09+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,244890000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q3,2018-07-01,2018-09-29,2019-11-05 14:03:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,69112000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q3,2018-07-01,2018-09-29,2019-11-05 14:03:09+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,130264000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q3,2018-07-01,2018-09-29,2019-11-05 14:03:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,199376000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q3,2018-07-01,2018-09-29,2019-11-05 14:03:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,45514000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q3,2018-07-01,2018-09-29,2019-11-05 14:03:09+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q3,2018-07-01,2018-09-29,2019-11-05 14:03:09+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1269000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q3,2018-07-01,2018-09-29,2019-11-05 14:03:09+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-249000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q3,2018-07-01,2018-09-29,2019-11-05 14:03:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1012000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q3,2018-07-01,2018-09-29,2019-11-05 14:03:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,46526000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q3,2018-07-01,2018-09-29,2019-11-05 14:03:09+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,15486000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q3,2018-07-01,2018-09-29,2019-11-05 14:03:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,31040000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q3,2018-07-01,2018-09-29,2019-11-05 14:03:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,31040000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q3,2018-07-01,2018-09-29,2019-11-05 14:03:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,31040000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q3,2018-07-01,2018-09-29,2019-11-05 14:03:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24269000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q3,2018-07-01,2018-09-29,2019-11-05 14:03:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.28
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q3,2018-07-01,2018-09-29,2019-11-05 14:03:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25001000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q3,2018-07-01,2018-09-29,2019-11-05 14:03:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.24
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q3,2018-07-01,2018-09-29,2019-11-05 14:03:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24300000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q3,2018-07-01,2018-09-29,2019-11-05 14:03:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.28
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q4,2018-09-30,2018-12-29,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,299023000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q4,2018-09-30,2018-12-29,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,299023000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q4,2018-09-30,2018-12-29,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,49467000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q4,2018-09-30,2018-12-29,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,49467000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q4,2018-09-30,2018-12-29,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,249556000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q4,2018-09-30,2018-12-29,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,68278000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q4,2018-09-30,2018-12-29,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,132710000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q4,2018-09-30,2018-12-29,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,200988000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q4,2018-09-30,2018-12-29,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,48568000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q4,2018-09-30,2018-12-29,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q4,2018-09-30,2018-12-29,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1287000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q4,2018-09-30,2018-12-29,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-383000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q4,2018-09-30,2018-12-29,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,895000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q4,2018-09-30,2018-12-29,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,49463000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q4,2018-09-30,2018-12-29,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,17132000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q4,2018-09-30,2018-12-29,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,32331000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q4,2018-09-30,2018-12-29,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,32331000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q4,2018-09-30,2018-12-29,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,32331000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q4,2018-09-30,2018-12-29,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24105000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q4,2018-09-30,2018-12-29,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.34
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q4,2018-09-30,2018-12-29,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24642000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q4,2018-09-30,2018-12-29,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.34
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q4,2018-09-30,2018-12-29,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24100000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2018.0,Q4,2018-09-30,2018-12-29,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.34
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q1,2018-12-30,2019-03-30,2019-05-07 15:43:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,272990000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q1,2018-12-30,2019-03-30,2019-05-07 15:43:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,272990000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q1,2018-12-30,2019-03-30,2019-05-07 15:43:13+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,45901000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q1,2018-12-30,2019-03-30,2019-05-07 15:43:13+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,45901000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q1,2018-12-30,2019-03-30,2019-05-07 15:43:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,227089000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q1,2018-12-30,2019-03-30,2019-05-07 15:43:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,69555000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q1,2018-12-30,2019-03-30,2019-05-07 15:43:13+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,122530000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q1,2018-12-30,2019-03-30,2019-05-07 15:43:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,192085000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q1,2018-12-30,2019-03-30,2019-05-07 15:43:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,35004000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q1,2018-12-30,2019-03-30,2019-05-07 15:43:13+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q1,2018-12-30,2019-03-30,2019-05-07 15:43:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1484000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q1,2018-12-30,2019-03-30,2019-05-07 15:43:13+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-182000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q1,2018-12-30,2019-03-30,2019-05-07 15:43:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1290000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q1,2018-12-30,2019-03-30,2019-05-07 15:43:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,36294000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q1,2018-12-30,2019-03-30,2019-05-07 15:43:13+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,12122000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q1,2018-12-30,2019-03-30,2019-05-07 15:43:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,24172000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q1,2018-12-30,2019-03-30,2019-05-07 15:43:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,24172000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q1,2018-12-30,2019-03-30,2019-05-07 15:43:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,24172000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q1,2018-12-30,2019-03-30,2019-05-07 15:43:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,23484000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q1,2018-12-30,2019-03-30,2019-05-07 15:43:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.03
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q1,2018-12-30,2019-03-30,2019-05-07 15:43:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,23927000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q1,2018-12-30,2019-03-30,2019-05-07 15:43:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.01
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q1,2018-12-30,2019-03-30,2019-05-07 15:43:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,23500000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q1,2018-12-30,2019-03-30,2019-05-07 15:43:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.03
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q2,2019-03-31,2019-06-29,2019-08-06 15:19:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,256016000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q2,2019-03-31,2019-06-29,2019-08-06 15:19:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,256016000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q2,2019-03-31,2019-06-29,2019-08-06 15:19:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,46494000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q2,2019-03-31,2019-06-29,2019-08-06 15:19:11+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,46494000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q2,2019-03-31,2019-06-29,2019-08-06 15:19:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,209522000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q2,2019-03-31,2019-06-29,2019-08-06 15:19:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,66854000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q2,2019-03-31,2019-06-29,2019-08-06 15:19:11+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,111511000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q2,2019-03-31,2019-06-29,2019-08-06 15:19:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,178365000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q2,2019-03-31,2019-06-29,2019-08-06 15:19:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,31157000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q2,2019-03-31,2019-06-29,2019-08-06 15:19:11+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q2,2019-03-31,2019-06-29,2019-08-06 15:19:11+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1301000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q2,2019-03-31,2019-06-29,2019-08-06 15:19:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,64000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q2,2019-03-31,2019-06-29,2019-08-06 15:19:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1355000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q2,2019-03-31,2019-06-29,2019-08-06 15:19:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,32512000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q2,2019-03-31,2019-06-29,2019-08-06 15:19:11+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11134000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q2,2019-03-31,2019-06-29,2019-08-06 15:19:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,21378000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q2,2019-03-31,2019-06-29,2019-08-06 15:19:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,21378000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q2,2019-03-31,2019-06-29,2019-08-06 15:19:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,21378000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q2,2019-03-31,2019-06-29,2019-08-06 15:19:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,23245000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q2,2019-03-31,2019-06-29,2019-08-06 15:19:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.92
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q2,2019-03-31,2019-06-29,2019-08-06 15:19:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,23370000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q2,2019-03-31,2019-06-29,2019-08-06 15:19:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.91
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q2,2019-03-31,2019-06-29,2019-08-06 15:19:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,23200000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q2,2019-03-31,2019-06-29,2019-08-06 15:19:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.92
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q3,2019-06-30,2019-09-28,2019-11-05 14:03:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,260598000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q3,2019-06-30,2019-09-28,2019-11-05 14:03:09+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,260598000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q3,2019-06-30,2019-09-28,2019-11-05 14:03:09+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,47819000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q3,2019-06-30,2019-09-28,2019-11-05 14:03:09+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,47819000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q3,2019-06-30,2019-09-28,2019-11-05 14:03:09+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,212779000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q3,2019-06-30,2019-09-28,2019-11-05 14:03:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,66262000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q3,2019-06-30,2019-09-28,2019-11-05 14:03:09+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,111059000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q3,2019-06-30,2019-09-28,2019-11-05 14:03:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,177321000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q3,2019-06-30,2019-09-28,2019-11-05 14:03:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,35458000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q3,2019-06-30,2019-09-28,2019-11-05 14:03:09+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,22000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q3,2019-06-30,2019-09-28,2019-11-05 14:03:09+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,966000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q3,2019-06-30,2019-09-28,2019-11-05 14:03:09+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-514000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q3,2019-06-30,2019-09-28,2019-11-05 14:03:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,430000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q3,2019-06-30,2019-09-28,2019-11-05 14:03:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,35888000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q3,2019-06-30,2019-09-28,2019-11-05 14:03:09+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11666000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q3,2019-06-30,2019-09-28,2019-11-05 14:03:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,24222000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q3,2019-06-30,2019-09-28,2019-11-05 14:03:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,24222000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q3,2019-06-30,2019-09-28,2019-11-05 14:03:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,24222000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q3,2019-06-30,2019-09-28,2019-11-05 14:03:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,22180000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q3,2019-06-30,2019-09-28,2019-11-05 14:03:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.09
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q3,2019-06-30,2019-09-28,2019-11-05 14:03:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,22223000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q3,2019-06-30,2019-09-28,2019-11-05 14:03:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.09
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q3,2019-06-30,2019-09-28,2019-11-05 14:03:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,22200000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q3,2019-06-30,2019-09-28,2019-11-05 14:03:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.09
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q4,2019-09-29,2019-12-28,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,271298000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q4,2019-09-29,2019-12-28,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,271298000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q4,2019-09-29,2019-12-28,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,47289000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q4,2019-09-29,2019-12-28,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,47289000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q4,2019-09-29,2019-12-28,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,224009000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q4,2019-09-29,2019-12-28,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,65060000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q4,2019-09-29,2019-12-28,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,114378000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q4,2019-09-29,2019-12-28,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,179438000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q4,2019-09-29,2019-12-28,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,44571000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q4,2019-09-29,2019-12-28,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,22000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q4,2019-09-29,2019-12-28,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,956000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q4,2019-09-29,2019-12-28,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,297000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q4,2019-09-29,2019-12-28,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1231000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q4,2019-09-29,2019-12-28,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,45802000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q4,2019-09-29,2019-12-28,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,15048000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q4,2019-09-29,2019-12-28,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,30754000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q4,2019-09-29,2019-12-28,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,30754000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q4,2019-09-29,2019-12-28,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,30754000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q4,2019-09-29,2019-12-28,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,22644000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q4,2019-09-29,2019-12-28,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.4
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q4,2019-09-29,2019-12-28,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,22818000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q4,2019-09-29,2019-12-28,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.4
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q4,2019-09-29,2019-12-28,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,22600000.0
USANA Health Sciences Inc,USNA,549300YTURXE814MAH96,0000896264,2019.0,Q4,2019-09-29,2019-12-28,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.4
